Hormonal postcoital contraception with an ethinylestradiol-norgestrel combination and two danazol regimens
article
OA: closed
CC0
⤵ 5 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study investigated the efficacy of hormonal postcoital contraception using ethinylestradiol-norgestrel and two danazol regimens.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (10)
- [Danazol: a new hormonal post-coital contraceptive method]. via openalex
- Danazol Suppresses Luteal Function in Vitro and in Vivo via openalex
- Side effects of danazol compared with an ethinyloestradiol/norgestrel combination when used for postcoital contraception via openalex
- The biochemistry of human endometrium after two regimens of postcoital contraception: a dl-norgestrel/ethinylestradiol combination or danazol via openalex
- doi:10.1016/0010-7824(78)90016-1 via openalex
- doi:10.1001/jama.1980.03310120024016 via openalex
- doi:10.1016/0010-7824(78)90006-9 via openalex
- doi:10.1016/s0015-0282(16)46157-1 via openalex
- doi:10.1016/s0010-7824(76)80052-2 via openalex
- doi:10.1016/s0015-0282(16)42793-7 via openalex
Cited by (5)
Source provenance
- openalex
- last seen: 2026-05-14T06:02:11.780192+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK